• Fresenius opened a new IV fluids production line in Kutno, Poland, expanding European output for essential hospital medicines.
• Manufacturing and warehouse infrastructure was expanded in Isola della Scala, Italy, lifting local capacity to support regional supply security.
• Combined investment totaled EUR 54 million, targeting supply chain resilience through a local-for-local manufacturing footprint.
• More than EUR 1 billion has been invested in European production over the past five years, spanning about 20 manufacturing sites.
• The projects align with a broader EU investment plan, including a EUR 400 million EIB financing agreement signed in 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fresenius SE & Co. KGaA published the original content used to generate this news brief on September 25, 2026, and is solely responsible for the information contained therein.